Integrated transcriptomic analysis reveals immune signatures distinguishing persistent versus resolving outcomes in MRSA bacteremia

By sjmartinez • June 7, 2024

Parmar R, Pickering H, Ahn R, Rossetti M, Gjertson DW, Ruffin F, Chan LC, Fowler VG Jr, Yeaman MR, Reed EF; MRSA Systems Immunology Group. Integrated transcriptomic analysis reveals immune signatures distinguishing persistent versus resolving outcomes in MRSA bacteremia. Front Immunol. 2024 May 23;15:1373553. doi: 10.3389/fimmu.2024.1373553. PMID: 38846955; PMCID: PMC11153731.

Tags: Harbor UCLA, host immunity, Infectious Diseases, Molecular Medicine, MRSA, persistence, proteomics, Publications, Staphylococcus aureus, Transcriptomics

TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma

Gross L, Mutisheva I, Hillen H, Robatel S, Wartenberg M, Ma F, Bäriswyl L, Lee DJ, Modlin RL, Z'graggen K, Schenk M. TREM-1 as a[...]

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept

Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew[...]

Coronary Plaque Volume in an Asymptomatic Population: Miami Heart Study at Baptist Health South Florida

Ichikawa K, Ronen S, Bishay R, Krishnan S, Benzing T, Kianoush S, Aldana-Bitar J, Cainzos-Achirica M, Feldman T, Fialkow J, Budoff MJ, Nasir K. Coronary[...]